API
< Back to all clusters
[HEALTH] · Bulgaria · 3 sources

started · updated

Bulgarian Supreme Administrative Court mandates NHIF to fund biomarker diagnostics

The Supreme Administrative Court of Bulgaria has ruled that the National Health Insurance Fund (NHIF) must pay for biomarker diagnostics for patients with oncological diseases. According to lawyer Silvia Velichkova, these tests are essential for determining correct treatment and directly impact the health and lives of cancer patients.

The court decision establishes that there is no legal basis for the NHIF to refuse payment for these diagnostics or to decline signing new contracts with medical facilities for these services. The ruling follows a dispute where the NHIF refused to pay for activities already performed for oncology patients under specific contracts.

Following this decision, it is expected that more medical institutions will enter into contracts to make these tests accessible and free of charge for patients. Additionally, a signal has been filed with the Commission for Protection against Discrimination on behalf of patients who had previously paid for these tests out of their own pockets.

Entities

Bulgarian Medical Union · Commission for Protection against Discrimination · National Health Insurance Fund · Silvia Velichkova · Supreme Administrative Court